Application of CRISPR-Cas9-Based Gene Editing Technology in Inherited Liver Diseases
International Journal of Molecular Sciences · 21.07.2026 · 27 (14) · 6469
DOI: 10.3390/ijms27146469 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.07.2026. Verfasst von Ran Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Liaoning Provincial Key Laboratory of Biotechnology and Molecular Drug Research and Development, School of Life Sciences, Liaoning Normal University,…. Hauptthemen laut MEDLINE: Liver Diseases, Gene Editing, CRISPR-Cas Systems. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Liaoning Normal University Doctoral Research Start-up Project, Liaoning Normal University.
Abstract (Originalsprache)
Inherited liver diseases are predominantly caused by monogenic mutations, and the vast majority of these conditions currently lack curative treatment options. Although liver transplantation may be used for patients with end-stage disease, it faces numerous challenges, including donor organ shortage, immune rejection, and the need for lifelong immunosuppression. In recent years, CRISPR-Cas9-based gene editing technology has advanced rapidly, offering transformative hope for the treatment of these diseases. This review systematically elucidates the working principles and technical advantages of the CRISPR-Cas9 system and its derived tools (base editing and prime editing), summarizes recent applications of these technologies in the treatment of hereditary liver diseases, and discusses the prospects and challenges of their clinical translation, aiming to provide a theoretical reference for future research in this field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Liaoning Provincial Key Laboratory of Biotechnology and Molecular Drug Research and Development, School of Life Sciences, Liaoning Normal University, Dalian 116082, China.
ORCID-Profile: Xiaoxia Shi
Förderung
- National Natural Science Foundation of China
- Liaoning Normal University Doctoral Research Start-up Project
- Liaoning Normal University
Zitieren
APA
Liu, R., Cong, S., Gao, Y., Xu, J., & Shi, X. (2026). Application of CRISPR-Cas9-Based Gene Editing Technology in Inherited Liver Diseases. International Journal of Molecular Sciences, 27(14), 6469. https://doi.org/10.3390/ijms27146469
Vancouver
Liu R, Cong S, Gao Y, Xu J, Shi X. Application of CRISPR-Cas9-Based Gene Editing Technology in Inherited Liver Diseases. International Journal of Molecular Sciences. 2026;27(14):6469. doi:10.3390/ijms27146469
BibTeX
@article{Liu2026,
author = {Liu, Ran and Cong, Shiqi and Gao, Yuan and Xu, Jiaqi and Shi, Xiaoxia},
title = {Application of CRISPR-Cas9-Based Gene Editing Technology in Inherited Liver Diseases},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6469},
doi = {10.3390/ijms27146469}
}
EUVIMED